China Antibodies

China Antibodies

With a rapidly growing economy, cost advantages, a skilled workforce, and a governmental commitment to the sciences, China is becoming increasingly important in the global biotechnology industry. Successful forays into high technology manufacturing and the increasing prestige of its scientific institutes have provided China with a strong platform for high-tech development.
China Antibodies is an essential resource for companies, investors and entrepreneurs interested in accessing China’s antibody industry. This report offers a comprehensive overview and analysis of China’s antibody industry together with a directory of more than 30 antibody-related enterprises. Detailed case studies and profiles of companies are included with information such as company size, customer segments, and executive profiles. This report includes cost data and addresses large-scale manufacturing.

I. Introduction and Overview

II.History of Antibodies in China

III.The Market Landscape of Distributors

IV.Products
• Antibodies for laboratory use
• Antibodies for diagnostics
• Protein chips
• Antibody therapeutics

V.Services
• Tailored preparation services
• Cost analysis

VI.Antibody Technology Landscape in China

VII.Players and Business Models in the Antibody Industry
• Institutes
• Companies

VIII. Government and Regulatory

IX.The Future

X.Opportunities for Multinationals

XI. Leading Antibody Researchers in China

XII. Case Studies

XIII. Profiles

XIV. Directory

XV. Figures
1.History of therapeutic antibodies
2.China's unit volume for HBV, HCV, and HIV diagnostic products
3.Number of antibody service providers (monoclonal vs. polyclonal)
4.Price comparisons for New Zealand rabbits
5.Price comparisons for BALB/c mice
6.Antibody-related papers published in China from 1994-2004
7.Antibody company segmentation
8.Antibody company core business area breakdown